发明授权
- 专利标题： Enzyme modulators and treatments
- 专利标题（中）： 酶调节剂和治疗
-
申请号： US11963740申请日： 2007-12-21
-
公开(公告)号： US08163756B2公开(公告)日： 2012-04-24
- 发明人: Daniel L. Flynn , Peter A. Petillo
- 申请人： Daniel L. Flynn , Peter A. Petillo
- 申请人地址： US KS Lawrence
- 专利权人： Deciphera Pharmaceuticals, LLC
- 当前专利权人： Deciphera Pharmaceuticals, LLC
- 当前专利权人地址： US KS Lawrence
- 代理机构： Cooley LLP
- 主分类号： C07D401/02
- IPC分类号： C07D401/02 ; A61K31/44
摘要：
Novel compounds and methods of using those compounds for the treatment of inflammatory conditions, hyperproliferative diseases, cancer, and diseases characterized by hyper-vascularization are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein, abl kinase protein, ber-abl kinase protein, braf kinase protein, VEGFR kinase protein, or PDGFR kinase protein comprises the step of contacting said kinase protein with the novel compounds.
公开/授权文献
- US20080113967A1 ENZYME MODULATORS AND TREATMENTS 公开/授权日：2008-05-15
信息查询
